This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: New York University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Farbod Mahmoudinobar
Introduction
Farbod Mahmoudinobar is an accomplished inventor based in Harrison, NJ (US). He has made significant contributions to the field of therapeutics and diagnostics, particularly in relation to viral infections. His innovative work focuses on the development of advanced testing methods for detecting viruses and antibodies.
Latest Patents
Farbod holds a patent for a groundbreaking invention titled "Therapeutics and point of care lateral-flow test for virus and antibodies using tagged assembled proteins." This patent presents a multivalent protein that targets the interaction of the SARS-CoV-2 spike receptor binding domain (RBD) with the human angiotensin-converting enzyme 2 (ACE2) receptor protein. The multivalent proteins developed by Farbod may also be utilized to treat subjects suffering from cancer, diseases, or viral infections. Additionally, his invention includes multiplex lateral flow test strips for the simultaneous detection of the virus and viral antibodies.
Career Highlights
Farbod is affiliated with New York University, where he continues to advance his research and innovation in the field of medical diagnostics. His work has the potential to significantly impact public health by providing rapid and accurate testing solutions.
Collaborations
Farbod collaborates with notable colleagues, including Jin Kim Montclare and Kamia Punia, who contribute to his research endeavors and help enhance the effectiveness of his inventions.
Conclusion
Farbod Mahmoudinobar's innovative contributions to the field of therapeutics and diagnostics exemplify the importance of research in combating viral infections. His patented technologies hold promise for improving health outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
